PeopleBio, Inc. (KOSDAQ: 304840)
South Korea
· Delayed Price · Currency is KRW
3,160.00
-90.00 (-2.77%)
Dec 19, 2024, 2:34 PM KST
PeopleBio Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '24 Dec 18, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 64,462 | 64,666 | 185,487 | 182,777 | 289,087 |
| Market Cap Growth | -16.40% | -65.14% | 1.48% | -36.77% | - |
| Enterprise Value | 66,315 | 73,663 | 173,842 | 167,284 | - |
| Last Close Price | 3065.00 | 3075.00 | 11401.96 | 11797.61 | 19063.22 |
| PS Ratio | 15.03 | 14.52 | 41.73 | 316.73 | 569.24 |
| PB Ratio | 0.02 | 3.29 | 31.31 | 9.61 | 32.75 |
| P/TBV Ratio | 10.57 | 4.08 | 377.99 | 14.04 | 33.03 |
| EV/Sales Ratio | 15.17 | 16.54 | 39.11 | 289.88 | - |
| Debt / Equity Ratio | 1.12 | 0.13 | 2.76 | 0.72 | 0.02 |
| Asset Turnover | 0.15 | 0.13 | 0.09 | 0.02 | - |
| Inventory Turnover | 1.29 | 2.16 | 7.18 | 5.52 | - |
| Quick Ratio | 0.71 | 2.39 | 0.74 | 1.33 | 19.02 |
| Current Ratio | 1.17 | 4.19 | 0.89 | 1.37 | 19.91 |
| Return on Equity (ROE) | -287.35% | -135.86% | -120.31% | -35.50% | - |
| Return on Assets (ROA) | -28.32% | -27.27% | -15.61% | -14.59% | - |
| Return on Capital (ROIC) | -49.15% | -42.84% | -26.56% | -21.63% | - |
| Earnings Yield | -18.74% | -24.80% | -7.71% | -2.57% | -1.52% |
| FCF Yield | -20.58% | -26.29% | -8.22% | -4.48% | -1.26% |
| Buyback Yield / Dilution | -41.85% | -13.30% | 8.80% | -32.18% | - |
| Total Shareholder Return | -41.85% | -13.30% | 8.80% | -32.18% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.